ISCA, CHRYSTEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.627
EU - Europa 1.766
AS - Asia 1.330
SA - Sud America 257
AF - Africa 45
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.043
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.581
IT - Italia 600
CN - Cina 401
SG - Singapore 380
IE - Irlanda 253
GB - Regno Unito 226
BR - Brasile 200
HK - Hong Kong 176
SE - Svezia 153
DE - Germania 151
VN - Vietnam 87
RU - Federazione Russa 78
FR - Francia 58
IN - India 54
FI - Finlandia 52
ID - Indonesia 41
KR - Corea 31
TR - Turchia 31
JP - Giappone 29
CA - Canada 27
LT - Lituania 26
NL - Olanda 24
AR - Argentina 22
BG - Bulgaria 22
EG - Egitto 22
TW - Taiwan 20
UA - Ucraina 20
IQ - Iraq 19
PL - Polonia 19
BE - Belgio 18
AU - Australia 14
CZ - Repubblica Ceca 14
ES - Italia 13
MX - Messico 13
MY - Malesia 13
CO - Colombia 10
PK - Pakistan 10
AT - Austria 9
BD - Bangladesh 9
ZA - Sudafrica 9
CL - Cile 8
MD - Moldavia 8
EC - Ecuador 7
VE - Venezuela 6
EU - Europa 4
GR - Grecia 4
PE - Perù 4
KE - Kenya 3
PS - Palestinian Territory 3
RO - Romania 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CH - Svizzera 2
ET - Etiopia 2
GH - Ghana 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
KH - Cambogia 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
ZW - Zimbabwe 1
Totale 6.043
Salva come PNG Salva come JPEG
Città #
Santa Clara 321
Ashburn 307
Chandler 255
Dublin 250
Singapore 211
Fairfield 179
Hong Kong 170
Dallas 132
Hefei 113
Nyköping 99
Houston 78
Southend 77
Beijing 74
London 73
New York 68
Woodbridge 67
Ann Arbor 63
Los Angeles 61
Seattle 59
Wilmington 49
Cambridge 48
Modena 46
Helsinki 44
Milan 44
Bologna 40
Dearborn 39
The Dalles 34
Munich 33
Jakarta 32
Chicago 30
Ho Chi Minh City 30
Fremont 29
Council Bluffs 27
Shanghai 27
Redwood City 26
Seoul 26
Moscow 24
San Diego 23
Rome 22
Sofia 22
Tokyo 22
São Paulo 21
Frankfurt am Main 20
Princeton 20
Asyut 18
Baghdad 17
Bremen 16
Portsmouth 16
San Giuliano Milanese 15
Banqiao 14
Hanoi 14
Reggio Emilia 14
Warsaw 14
Brooklyn 13
Jacksonville 13
Orem 13
Parma 13
Brussels 12
Des Moines 12
Dong Ket 12
Lauterbourg 12
Lawrence 12
Eugene 11
Nuremberg 11
Poplar 11
Sassuolo 11
Columbus 10
Denver 10
Düsseldorf 10
Izmir 10
Toronto 10
Atlanta 9
Brno 9
Castelvetrano 9
Guangzhou 9
Phoenix 9
San Jose 9
Absecon 8
Belo Horizonte 8
Chisinau 8
Paris 8
Redondo Beach 8
Amsterdam 7
Buffalo 7
Manchester 7
Mexico City 7
Mumbai 7
Porto Alegre 7
Santorso 7
Genoa 6
Harbin 6
Johannesburg 6
Melbourne 6
Mykolayiv 6
Palermo 6
Sydney 6
Turku 6
Venezia 6
Vicenza 6
Vienna 6
Totale 3.988
Salva come PNG Salva come JPEG
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 527
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 390
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 321
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 298
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 294
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 281
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 248
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 238
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 230
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 223
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 222
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 220
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 217
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 216
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 213
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 210
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 206
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 201
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 179
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 172
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 169
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 153
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 150
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 149
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 133
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 125
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 121
Totale 6.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 0 0 0 0 0 39 15 42 42 51 12 71
2021/2022526 57 41 33 28 20 46 20 24 47 53 95 62
2022/2023978 79 121 58 82 80 79 16 70 300 29 32 32
2023/2024607 28 25 51 65 59 75 76 57 33 30 54 54
2024/20251.552 48 18 38 109 281 209 140 112 173 105 124 195
2025/20261.427 208 84 284 277 411 163 0 0 0 0 0 0
Totale 6.106